ASO Author Reflections: C-Reactive Protein/Albumin Ratio as a Prognostic Factor in Patients with Malignant Pleural Mesothelioma: What Does the Novel Index Represent?
作者信息
Takamori Shinkichi, Takenoyama Mitsuhiro
机构信息
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.
出版信息
Ann Surg Oncol. 2018 Dec;25(Suppl 3):958-959. doi: 10.1245/s10434-018-6920-9. Epub 2018 Oct 23.
PMID:30353392
Abstract
摘要
相似文献
1
ASO Author Reflections: C-Reactive Protein/Albumin Ratio as a Prognostic Factor in Patients with Malignant Pleural Mesothelioma: What Does the Novel Index Represent?
Ann Surg Oncol. 2018 Dec;25(Suppl 3):958-959. doi: 10.1245/s10434-018-6920-9. Epub 2018 Oct 23.
2
The C-Reactive Protein/Albumin Ratio May Predict the Long-Term Outcome in Patients with Malignant Pleural Mesothelioma.C反应蛋白与白蛋白比值可能预测恶性胸膜间皮瘤患者的长期预后。
Ann Surg Oncol. 2018 Jun;25(6):1471-1472. doi: 10.1245/s10434-018-6420-y. Epub 2018 Mar 7.
3
ASO Author Reflections: The C-Reactive Protein (CRP)-Albumin Ratio May Be Useful as the Most Prognostic Index Among the Immuno-nutritional Parameters Using CRP and Albumin for Resected NSCLC.ASO作者反思：在使用C反应蛋白（CRP）和白蛋白的免疫营养参数中，C反应蛋白-白蛋白比值可能是用于评估切除的非小细胞肺癌（NSCLC）预后的最有用指标。
Ann Surg Oncol. 2021 Jun;28(6):3055-3056. doi: 10.1245/s10434-020-09254-3. Epub 2020 Oct 23.
4
The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study.C 反应蛋白/白蛋白比值是恶性胸膜间皮瘤患者的一种新的显著预后因素：一项回顾性多机构研究。
Ann Surg Oncol. 2018 Jun;25(6):1555-1563. doi: 10.1245/s10434-018-6385-x. Epub 2018 Mar 2.
5
ASO Author Reflections: Management of Malignant Peritoneal Mesothelioma.ASO作者反思：恶性腹膜间皮瘤的管理
Ann Surg Oncol. 2018 Dec;25(Suppl 3):767-768. doi: 10.1245/s10434-018-7021-5. Epub 2018 Nov 12.
6
ASO Author Reflections: Postoperative Radiotherapy for Patients with Mesothelioma-Past, Present, and Future.ASO作者反思：间皮瘤患者的术后放疗——过去、现在与未来
Ann Surg Oncol. 2019 Dec;26(Suppl 3):635-636. doi: 10.1245/s10434-019-07467-9. Epub 2019 Jun 14.
7
Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan.恶性胸膜间皮瘤的生存和预后因素：日本西部 314 例患者的回顾性研究。
Jpn J Clin Oncol. 2011 Jan;41(1):32-9. doi: 10.1093/jjco/hyq159. Epub 2010 Aug 26.
8
Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis.手术诊断和/或胸膜固定术后胸膜间皮瘤的结果和预后因素。
J Thorac Cardiovasc Surg. 2013 May;145(5):1305-11. doi: 10.1016/j.jtcvs.2012.09.023. Epub 2012 Oct 13.
9
Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysis.预处理血清 C 反应蛋白水平预测恶性胸膜间皮瘤患者接受包括根治性手术在内的多模式治疗获益：一项回顾性多中心分析。
Ann Surg. 2012 Aug;256(2):357-62. doi: 10.1097/SLA.0b013e3182602af4.
10
Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma.恶性胸膜间皮瘤患者胸腔积液中的透明质酸含量作为一个预后因素。
Cancer. 2001 Sep 1;92(5):1224-30. doi: 10.1002/1097-0142(20010901)92:5<1224::aid-cncr1441>3.0.co;2-u.
Zotero 插件